gip/glp-1 agonist The Sustained Effects of a Dual Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes Is Tirzepatide a GLP-1? The

What is oral chelation

DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-319-74056-0 Online ISBN: 978-3-319-74057-7 eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Tirzepatide, the dual GIP and GLP-1 agonist, sits a clear step above semaglutide on weight loss and has added indications of its own, including obstructive sleep apnea

Clinicians should also consider alternative medical explanations for new-onset fatigue, including thyroid dysfunction, anemia, sleep apnea (which may improve or persist despite weight loss), chronic kidney disease, or cardiovascular conditions